| Property Name | Property Value | Unit | Raw Value | Raw Unit | Reference |
|---|---|---|---|---|---|
| Log P | 5.37 | - | 5.37 | - | FDA Advisory Committee Briefing Document. |
| Boiling Point | 421.5 | ℃ | 421.5 | ℃ | 'MSDS' |
| Melting Point | 222.0 | ℃ | 221-223 | ℃ | U.S. Patent 3,966,757. |
| pKa | 9.43 | - | 9.43 | - | FDA Advisory Committee Briefing Document. |
| Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Reference |
|---|---|---|---|---|---|---|
| Bioavailability | 72.0 | % | >72 | % | PO, oral; | DRUGBANK |
| C Max | 1.3 | ng/ml | 1.26 | ng/ml | PO, oral; | DRUGBANK |
| T Max | 3.5 | h | 2-5 | h | PO, oral; | DRUGBANK | T Max | 3.0 | h | 3 | h | PO, oral; | DRUGBANK |
| Clearance | 17.6 | L/h | 17.6 | L/h | Total clearance; intravenous injection, IV; | DRUGBANK |
| Volume of Distribution | 300.0 | L | 300.0 | L | DRUGBANK | |
| Half-life | 11.0 | h | 11 | h | elimination half-life; | DRUGBANK |
| Eliminate Route | 94.0 | % | 94 | % | Urinary excretion; | DRUGBANK | Eliminate Route | 0.93 | % | 0.93 | % | Faeces excretion; | DRUGBANK |
| Protein Binding | 55.0 | % | ~55 | % | DRUGBANK |
Not Available